Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Opinion
October 08, 2021 11:16 AM

Cancer care must crack the diversity code

Dr. Richard Barakat
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Dr. Richard Barakat
    Dr. Richard Barakat is physician-in-chief and director of the Northwell Health Cancer Institute.

    We can credit clinical trials for great improvements made in cancer care in recent years. Death rates for 11 of the 19 most common cancers in men and 14 of the 20 most common cancers in women decreased between 2014 and 2018.

    But there's a large hole in these improvements: a lack of diversity.

    A 2020 report from the American Association of Cancer Research demonstrated that African-American men have a 111% higher risk of dying from prostate cancer, while African-American women have a 39% higher risk of dying from breast cancer. In addition, African-Americans have the highest overall death rate from cancer over the past four decades.

    While African-Americans constitute 13.4% of the population, they represented only 11% of patients accrued to National Cancer Institute clinical trials in 2019. Similarly, the accrual rate for Hispanics was 10%, despite representing 18.5% of the U.S. population.

    This must change. And when it does, thousands of lives could potentially be saved annually.

    In cancer—and all clinical trials—ethnic diversity is genetic diversity, and unless we successfully enroll people from all ethnic and racial origins, our advancements will fail to be inclusive.

    Cancer treatments are more often focused on genetic profiling because cancer is not a traditional disease. The routine treatment of surgery, chemotherapy and radiation could work for some and not others, based largely on genetic factors.

    That's why treatment options are most effective when we tailor them to the genetic profile of a patient's particular tumor as well as their genetic background. The research and medical community need to be able to offer treatment options that make the most of that valuable information.

    How do we move forward?

    To start, we must regain the trust of people who historically have regarded the healthcare industry with suspicion. For example, African-Americans have long been wary of participating in clinical trials. There have been documented abuses throughout our nation's history. African-Americans have also often had less access to healthcare in general.

    And our challenge goes beyond the African-American population.

    Other ethnic groups are also underrepresented in clinical trials. In some cases, it's also a lack of trust. In many others, it's because there aren't enough people from that background available to us. That's where health systems in the most diverse areas of the country must step up.

    The unique opportunity that my colleagues and I at Northwell Health have is that the region we serve is as richly diverse as any area of the U.S. For example, the borough of Queens is one of the most ethnically diverse counties in the world. Oncologists treat cancers unique to specific populations, like ones caused by genetic mutations prevalent in the Asian community. Our health system treats more New Yorkers who have cancer than any other provider—about 19,000 new patients each year.

    Our cancer institute also participates in more than 200 active clinical trials, and we have focused greatly on enrolling a diverse group of patients that properly represents the population of this region. We are seeing some positive results. Even as COVID-19 disrupted so much research in 2020, we were able to enroll 52 cancer patients in interventional treatment, 31% of whom were from underrepresented communities.

    The pandemic has forced us in healthcare to rethink—and for the better—how to roll out trials throughout every discipline. For example, my colleagues at the Feinstein Institutes rolled out the health system's first fully virtual outpatient clinical trial looking at the safety and efficacy of famotidine, the generic name for the common heartburn drug Pepcid AC, to treat mild to moderate COVID patients at home. Being able to take a trial out of a hospital setting increased diversity and delivered potentially life-changing treatments, all thanks to FedEx and an iPad. These types of trials can be done in other health systems around the world.

    To properly treat a diverse patient population—and entice them to join clinical trials—health systems in increasingly diverse cities must employ staffers who speak languages such as Spanish, Chinese, Korean, Russian, Hindi and Bengali. Next, it's key to translate clinical trial information into these, and other languages. This will make all the difference in communication. While most trials are translated into Spanish, residents who speak other languages might be left unaware of clinical trial options.

    There's also the challenge of having diverse communities trust clinical trials. We can better gain that trust by using doctors who have the same background as patients.

    By engaging with our community partners, we can work to educate racial and ethnic minorities about the benefits of cancer clinical trials. We hope these enhancements will open communication and shed light on clinical trial options for patients who would otherwise be left in the dark about cutting-edge treatments.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    27256428336_89d106069f_b 790px_i_i_i.jpg
    Compromise may mean continued reprieve for 'Obamacare' preventive care mandates
    artificial intelligence - AI
    A.I. a top issue at this weekend's AMA policy meeting
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing